Particles in exhaled air (PExA): non-invasive phenotyping of small airways disease in adult asthma.

RATIONALE

Asthma is often characterised by inflammation, damage and dysfunction of the small airways, but no standardised biomarkers are available.

OBJECTIVES

Using a novel approach-particles in exhaled air (PExA)-we sought to (a) sample and analyse abundant protein biomarkers: surfactant protein A (SPA) and albumin in adult asthmatic and healthy patients and (b) relate protein concentrations with physiological markers using phenotyping.

METHODS

83 adult asthmatics and 21 healthy volunteers were recruited from a discovery cohort in Leicester, UK, and 32 adult asthmatics as replication cohort from Sweden. Markers of airways closure/small airways dysfunction were evaluated using forced vital capacity, impulse oscillometry and multiple breath washout. SPA/albumin from PEx (PExA sample) were analysed using ELISA and corrected for acquired particle mass. Topological data analysis (TDA) was applied to small airway physiology and PExA protein data to identify phenotypes.

RESULTS

PExA manoeuvres were feasible, including severe asthmatic subjects. TDA identified a clinically important phenotype of asthmatic patients with multiple physiological markers of peripheral airway dysfunction, and significantly lower levels of both SPA and albumin.

CONCLUSION

We report that the PExA method is feasible across the spectrum of asthma severity and could be used to identify small airway disease phenotypes.